10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,465 | +2117.6% | 127,619 | +1279.2% | 0.03% | +1350.0% |
| Q2 2023 | $517 | +0.2% | 9,253 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $516 | +53.1% | 9,253 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $337 | -99.9% | 9,253 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $264,000 | -37.0% | 9,253 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $419,000 | -40.5% | 9,253 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $704,000 | -48.9% | 9,253 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $1,378,000 | +2.3% | 9,253 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $1,347,000 | -25.7% | 9,253 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $1,812,000 | +8.2% | 9,253 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $1,675,000 | +27.9% | 9,253 | 0.0% | 0.01% | +33.3% |
| Q4 2020 | $1,310,000 | – | 9,253 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,753,528 | $133,391,000 | 100.00% |
| Foresite Capital Management I, LLC | 750,000 | $57,053,000 | 99.71% |
| 12 West Capital Management LP | 2,518,500 | $191,582,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 1,336,253 | $101,649,000 | 9.59% |
| Blue Water Life Science Advisors, LP | 211,917 | $16,121,000 | 7.65% |
| Decheng Capital Management III (Cayman), LLC | 303,984 | $23,124,000 | 7.09% |
| FINANCIAL CONSULATE, INC | 154,942 | $11,786,000 | 4.53% |
| Evolutionary Tree Capital Management, LLC | 54,128 | $4,118,000 | 2.86% |
| HARVARD MANAGEMENT CO INC | 186,143 | $14,160,000 | 1.43% |
| Brown Capital Management | 1,663,469 | $126,540,000 | 1.26% |